Mobile Sleep Apnea Screening Tools Market Report 2026

The mobile sleep apnea screening tools market size has grown rapidly in recent years. It will grow from $47.68 billion in 2025 to $56.01 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to rising prevalence of sleep apnea disorders, increasing awareness of sleep-related health issues, limited access to sleep laboratories in rural areas, growth in adoption of wearable health devices, increasing healthcare digitization.

The mobile sleep apnea screening tools market size is expected to see rapid growth in the next few years. It will grow to $107.54 billion by 2030 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to rising demand for home-based diagnostic solutions, increasing adoption of ai-enabled health monitoring tools, expansion of telehealth and remote patient monitoring, growing geriatric population with sleep disorders, increasing focus on preventive healthcare and early diagnosis. Major trends in the forecast period include rising adoption of wearable-based sleep monitoring devices for continuous at-home apnea risk detection, increasing integration of ai-driven predictive analytics for early sleep disorder identification, growing use of smartphone-connected respiratory sensors for non-invasive sleep tracking, expansion of cloud-based sleep health platforms enabling remote physician monitoring, increasing demand for home-based sleep diagnostics reducing dependence on clinical sleep labs.

The increasing adoption of mobile health applications is expected to significantly contribute to the growth of the mobile sleep apnea screening tools market. Mobile health applications are digital platforms accessible via smartphones that enable users to track health conditions, access medical services, and share real-time health data with healthcare providers. Their adoption is rising due to the growing dependence on smartphones for convenient, remote, and on-demand healthcare access. Mobile sleep apnea screening tools leverage these applications to facilitate remote sleep monitoring, real-time data transmission, and early identification of sleep disorders, reducing the necessity for in-person hospital visits. For instance, in December 2025, according to the National Health Service, a UK-based public healthcare organization, 67.8 million repeat prescriptions were ordered through the NHS App between December 2024 and November 2025, with 62.3 million logins recorded in November alone, representing a 43% rise compared to the previous monthly average. Therefore, the increasing adoption of mobile health applications is contributing to the growth of the mobile sleep apnea screening tools market.

Leading companies operating in the mobile sleep apnea screening tools market are focusing on technological advancement such as AI-powered acoustic sleep monitoring systems to improve diagnostic accuracy, enable non-invasive testing, and support remote patient monitoring. AI-powered acoustic sleep monitoring systems refer to wearable or mobile-enabled technologies that capture physiological sound signals generated by breathing and analyze them using artificial intelligence algorithms to detect sleep apnea events and respiratory irregularities without the need for complex wired setups. For example, in June 2023, Acurable, a UK-based medical device company, launched the AcuPebble Ox100. The device features a non-invasive acoustic sensor placed on the neck, AI-driven automated respiratory biomarker analysis, and mobile-connected data transfer to a secure cloud platform for remote diagnosis, enabling efficient at-home sleep testing with minimal clinical supervision.

In July 2024, EnsoData, a US-based provider of artificial intelligence-driven healthcare analytics and sleep diagnostic solutions, acquired sleep testing diagnostic technology from Resonea for an undisclosed value. With this acquisition, EnsoData aims to improve its mobile-first sleep apnea screening capabilities by incorporating acoustic flow and microphone-based data analysis into its platform, enabling scalable smartphone-based pre-screening and enhanced home sleep testing diagnostics. Resonea is a US-based provider of mobile sleep apnea screening technology, offering smartphone-based acoustic analysis solutions for detecting respiratory events and supporting early diagnosis of sleep disorders.

Major companies operating in the mobile sleep apnea screening tools market are Apple Inc., Samsung Electronics Co. Ltd., Inspire Medical Systems Inc., Koninklijke Philips N. V., ResMed Inc., Nihon Kohden Corporation, Fisher & Paykel Healthcare Corporation Limited, Contec Medical Systems Co. Ltd., Beurer GmbH, Withings S. A., SomnoMed Limited, Cadwell Industries Inc., BMC Medical Co. Ltd., Sibel S. A. U., CleveMed Inc., Sunrise Sleep Technologies SA, Compumedics Limited, Acurable Limited, Advanced Brain Monitoring Inc., Circadiance LLC, Braebon Medical Corporation, Oxitone Medical Ltd., Löwenstein Medical Technology GmbH + Co. KG, Belun Technology Company Limited, Nox Medical ehf.

North America was the largest region in the mobile sleep apnea screening tools market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile sleep apnea screening tools market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the mobile sleep apnea screening tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mobile sleep apnea screening tools market consists of sales of wearable devices, portable sleep monitors, pulse oximeters, smartwatches, biosensors, respiratory monitoring devices, mobile-connected diagnostic devices, and sleep tracking accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.